Loading…

Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience

Abstract Context: Sequential induction chemotherapy with cisplatin and 5-fluorouracil ( P F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue. Aims: The study was designed to evaluate the beneficial role o...

Full description

Saved in:
Bibliographic Details
Published in:Indian journal of medical and paediatric oncology 2015-01, Vol.36 (1), p.43-48
Main Authors: Chhatui, Bappaditya, Roy, Sanjoy, Maji, Tapas, Lahiri, Debarshi, Biswas, Jaydip
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3
cites
container_end_page 48
container_issue 1
container_start_page 43
container_title Indian journal of medical and paediatric oncology
container_volume 36
creator Chhatui, Bappaditya
Roy, Sanjoy
Maji, Tapas
Lahiri, Debarshi
Biswas, Jaydip
description Abstract Context: Sequential induction chemotherapy with cisplatin and 5-fluorouracil ( P F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue. Aims: The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue. Settings and Design: Phase II randomized, prospective, open-labeled, single-institutional study. Methods and Material: Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A. Statistical analysis used: Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used. Results: The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy. Conclusions: In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients.
doi_str_mv 10.4103/0971-5851.151782
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4363850</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A403252966</galeid><sourcerecordid>A403252966</sourcerecordid><originalsourceid>FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3</originalsourceid><addsrcrecordid>eNp1kktv1DAUhSMEoqWwZ4UiISE2M_UjthMWlUYVj5EqsYG15bFvJq4ce3CcwvwI_jNOU4YZBMrCse93jnWvT1G8xGhZYUQvUSPwgtUMLzHDoiaPivN8xBYEk-bx_f9cPiueDcMtQpRhXj8tzgirMWKiOi9-rvt-9KEPZnQqgSmVTxBtiKXuoA-pg6h2-7INzoXvubzZlzp4PcYIPs1MVMYeQOtLF7Rybl8qc6e8zpoU_HaEUk-7-K5c-XLth2TTmGzwypXwY5evhFx9XjxplRvgxcN6UXz98P7L9afFzeeP6-vVzUIzTtJCMaU4qI1puWJMEypE3fAKMcU1I0oIbWgNeW8Mw5WpodFENBVvDQUCFOhFcTX77sZND0bnXqJychdtr-JeBmXlacXbTm7DnawopzVD2eDtg0EM30YYkuztoME55SGMg8ScC1oxIXhGX_-F3oYx5r4nijVCMFLVf6itciCtb0O-V0-mclUhShhp-OS1_AeVPwO9ze8Crc3nJ4I3R4IOlEvdENz95IdTEM2gjmEYIrSHYWAkp6zJKUxyCpOcs5Ylr46HeBD8DlcGLmcgdRZ6OOr7f5a_AEfJ37U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1659775248</pqid></control><display><type>article</type><title>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Chhatui, Bappaditya ; Roy, Sanjoy ; Maji, Tapas ; Lahiri, Debarshi ; Biswas, Jaydip</creator><creatorcontrib>Chhatui, Bappaditya ; Roy, Sanjoy ; Maji, Tapas ; Lahiri, Debarshi ; Biswas, Jaydip ; Devleena</creatorcontrib><description>Abstract Context: Sequential induction chemotherapy with cisplatin and 5-fluorouracil ( P F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue. Aims: The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue. Settings and Design: Phase II randomized, prospective, open-labeled, single-institutional study. Methods and Material: Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A. Statistical analysis used: Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used. Results: The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy. Conclusions: In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients.</description><identifier>ISSN: 0971-5851</identifier><identifier>EISSN: 0975-2129</identifier><identifier>DOI: 10.4103/0971-5851.151782</identifier><identifier>PMID: 25810574</identifier><language>eng</language><publisher>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. Ltd</publisher><subject>Cancer therapies ; Care and treatment ; Chemotherapy ; Cisplatin ; Dosage and administration ; Dysphagia ; Fluorouracil ; Interferon ; Interferon alfa-2b ; Lymphatic system ; Metastasis ; Methods ; Original ; ORIGINAL ARTICLE ; Ovarian cancer ; Patients ; Quality of life ; Radiation therapy ; Radiotherapy ; Response rates ; Surgery ; Tobacco ; Tongue cancer</subject><ispartof>Indian journal of medical and paediatric oncology, 2015-01, Vol.36 (1), p.43-48</ispartof><rights>Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)</rights><rights>COPYRIGHT 2015 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications &amp; Media Pvt Ltd Jan-Mar 2015</rights><rights>Copyright: © Indian Journal of Medical and Paediatric Oncology 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363850/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1659775248?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25810574$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chhatui, Bappaditya</creatorcontrib><creatorcontrib>Roy, Sanjoy</creatorcontrib><creatorcontrib>Maji, Tapas</creatorcontrib><creatorcontrib>Lahiri, Debarshi</creatorcontrib><creatorcontrib>Biswas, Jaydip</creatorcontrib><creatorcontrib>Devleena</creatorcontrib><title>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</title><title>Indian journal of medical and paediatric oncology</title><addtitle>Indian J Med Paediatr Oncol</addtitle><description>Abstract Context: Sequential induction chemotherapy with cisplatin and 5-fluorouracil ( P F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue. Aims: The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue. Settings and Design: Phase II randomized, prospective, open-labeled, single-institutional study. Methods and Material: Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A. Statistical analysis used: Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used. Results: The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy. Conclusions: In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients.</description><subject>Cancer therapies</subject><subject>Care and treatment</subject><subject>Chemotherapy</subject><subject>Cisplatin</subject><subject>Dosage and administration</subject><subject>Dysphagia</subject><subject>Fluorouracil</subject><subject>Interferon</subject><subject>Interferon alfa-2b</subject><subject>Lymphatic system</subject><subject>Metastasis</subject><subject>Methods</subject><subject>Original</subject><subject>ORIGINAL ARTICLE</subject><subject>Ovarian cancer</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Radiation therapy</subject><subject>Radiotherapy</subject><subject>Response rates</subject><subject>Surgery</subject><subject>Tobacco</subject><subject>Tongue cancer</subject><issn>0971-5851</issn><issn>0975-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>0U6</sourceid><sourceid>PIMPY</sourceid><recordid>eNp1kktv1DAUhSMEoqWwZ4UiISE2M_UjthMWlUYVj5EqsYG15bFvJq4ce3CcwvwI_jNOU4YZBMrCse93jnWvT1G8xGhZYUQvUSPwgtUMLzHDoiaPivN8xBYEk-bx_f9cPiueDcMtQpRhXj8tzgirMWKiOi9-rvt-9KEPZnQqgSmVTxBtiKXuoA-pg6h2-7INzoXvubzZlzp4PcYIPs1MVMYeQOtLF7Rybl8qc6e8zpoU_HaEUk-7-K5c-XLth2TTmGzwypXwY5evhFx9XjxplRvgxcN6UXz98P7L9afFzeeP6-vVzUIzTtJCMaU4qI1puWJMEypE3fAKMcU1I0oIbWgNeW8Mw5WpodFENBVvDQUCFOhFcTX77sZND0bnXqJychdtr-JeBmXlacXbTm7DnawopzVD2eDtg0EM30YYkuztoME55SGMg8ScC1oxIXhGX_-F3oYx5r4nijVCMFLVf6itciCtb0O-V0-mclUhShhp-OS1_AeVPwO9ze8Crc3nJ4I3R4IOlEvdENz95IdTEM2gjmEYIrSHYWAkp6zJKUxyCpOcs5Ylr46HeBD8DlcGLmcgdRZ6OOr7f5a_AEfJ37U</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Chhatui, Bappaditya</creator><creator>Roy, Sanjoy</creator><creator>Maji, Tapas</creator><creator>Lahiri, Debarshi</creator><creator>Biswas, Jaydip</creator><general>Thieme Medical and Scientific Publishers Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt Ltd</general><scope>0U6</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PADUT</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</title><author>Chhatui, Bappaditya ; Roy, Sanjoy ; Maji, Tapas ; Lahiri, Debarshi ; Biswas, Jaydip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Cancer therapies</topic><topic>Care and treatment</topic><topic>Chemotherapy</topic><topic>Cisplatin</topic><topic>Dosage and administration</topic><topic>Dysphagia</topic><topic>Fluorouracil</topic><topic>Interferon</topic><topic>Interferon alfa-2b</topic><topic>Lymphatic system</topic><topic>Metastasis</topic><topic>Methods</topic><topic>Original</topic><topic>ORIGINAL ARTICLE</topic><topic>Ovarian cancer</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Radiation therapy</topic><topic>Radiotherapy</topic><topic>Response rates</topic><topic>Surgery</topic><topic>Tobacco</topic><topic>Tongue cancer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chhatui, Bappaditya</creatorcontrib><creatorcontrib>Roy, Sanjoy</creatorcontrib><creatorcontrib>Maji, Tapas</creatorcontrib><creatorcontrib>Lahiri, Debarshi</creatorcontrib><creatorcontrib>Biswas, Jaydip</creatorcontrib><creatorcontrib>Devleena</creatorcontrib><collection>Thieme Connect Journals Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Research Library China</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Indian journal of medical and paediatric oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chhatui, Bappaditya</au><au>Roy, Sanjoy</au><au>Maji, Tapas</au><au>Lahiri, Debarshi</au><au>Biswas, Jaydip</au><aucorp>Devleena</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience</atitle><jtitle>Indian journal of medical and paediatric oncology</jtitle><addtitle>Indian J Med Paediatr Oncol</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>36</volume><issue>1</issue><spage>43</spage><epage>48</epage><pages>43-48</pages><issn>0971-5851</issn><eissn>0975-2129</eissn><abstract>Abstract Context: Sequential induction chemotherapy with cisplatin and 5-fluorouracil ( P F) along with interferon-alpha2b and concurrent chemoradiation offers superior loco-regional control for locally advanced carcinoma of oral tongue. Aims: The study was designed to evaluate the beneficial role of induction PF chemotherapy and interferon-alpha2b followed by chemoradiation over definitive chemoradiation only for patients with locally advanced carcinoma of oral tongue. Settings and Design: Phase II randomized, prospective, open-labeled, single-institutional study. Methods and Material: Fifty patients were randomized into 2 arms. Arm A patients were treated with induction chemotherapy with PF regimen for 3 cycles and interferon alpha 2b, 3MU biweekly for 6 such followed by chemoradiation with cisplatin 30 mg/ m 2 / week and external radiotherapy. Arm B patients received chemoradiation only, in the same dose schedule as in Arm A. Statistical analysis used: Chi-square test was done to find out the statistical correlation between the two arms. For plotting the disease-free survival (DFS) and overall survival (OS) for the two arms, Kaplan-Meier method was used. Results: The loco-regional response rate of patients treated with interferon containing induction chemotherapy followed by concurrent chemoradiation was superior to concurrent chemoradiation only. However the toxicities and treatment interruption were more in patients treated with induction chemotherapy. Conclusions: In locally advanced carcinoma of oral tongue, induction chemotherapy with cisplatin and 5-fluorouracil (PF) along with interferon alpha 2b followed by concurrent chemoradiation may produce superior loco-regional control with manageable toxicities that needs to be validated by more randomized trials with adequate number of patients.</abstract><cop>A-12, 2nd Floor, Sector 2, Noida-201301 UP, India</cop><pub>Thieme Medical and Scientific Publishers Pvt. Ltd</pub><pmid>25810574</pmid><doi>10.4103/0971-5851.151782</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0971-5851
ispartof Indian journal of medical and paediatric oncology, 2015-01, Vol.36 (1), p.43-48
issn 0971-5851
0975-2129
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4363850
source Publicly Available Content Database; PubMed Central
subjects Cancer therapies
Care and treatment
Chemotherapy
Cisplatin
Dosage and administration
Dysphagia
Fluorouracil
Interferon
Interferon alfa-2b
Lymphatic system
Metastasis
Methods
Original
ORIGINAL ARTICLE
Ovarian cancer
Patients
Quality of life
Radiation therapy
Radiotherapy
Response rates
Surgery
Tobacco
Tongue cancer
title Immunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T10%3A24%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunomodulated%20anterior%20chemotherapy%20followed%20by%20concurrent%20chemoradiotherapy%20in%20locally%20advanced%20tongue%20cancer:%20An%20Institutional%20experience&rft.jtitle=Indian%20journal%20of%20medical%20and%20paediatric%20oncology&rft.au=Chhatui,%20Bappaditya&rft.aucorp=Devleena&rft.date=2015-01-01&rft.volume=36&rft.issue=1&rft.spage=43&rft.epage=48&rft.pages=43-48&rft.issn=0971-5851&rft.eissn=0975-2129&rft_id=info:doi/10.4103/0971-5851.151782&rft_dat=%3Cgale_pubme%3EA403252966%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c562t-a5aa6eabdf6a55c2377896405a6c52a77cd38e405dd514d8e9c27946fd3e2e3e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1659775248&rft_id=info:pmid/25810574&rft_galeid=A403252966&rfr_iscdi=true